Ligation-occluded Endoscopic Injection Sclerotherapy: a Novel Retrograde Strategy for Gastroesophageal Varices Obliteration.

Wei Wu,Qukai Liu,Weiguang Li,Jiali Kan,Qi Wang,Lifu Wang
DOI: https://doi.org/10.1055/a-1275-9674
2020-01-01
Endoscopy
Abstract:We propose a novel retrograde obliteration strategy, ligation-occluded endoscopic injection sclerotherapy (LOEIS), for management of gastroesophageal varices. We report on a patient with GOV1+2 varices who benefitted from this strategy (▶Fig. 1 a). She underwent endoscopy for recurrent variceal bleeding. Conventional variceal obturation with sclerosant [1] (1% lauromacrogol with methylene blue as tracer agent) to the first two cardiac varices was successful [2]. We tried to obturate a third cardiac varix with a caliber of 1.8–2.5mm on endosonography, but failed to achieve accurate injection; unfortunately, this attempt also resulted in active bleeding (▶Fig. 1b). We decided to perform LOEIS. The downstream esophageal extension of the bleeding cardiac varix was carefully identified. Esophageal variceal ligation (Super 7; Boston Scientific, Marlborough, Massachusetts, USA) was performed. Injection therapy was then carried out on this varix at 1–2 cm distal to the rubber band and 2 cm proximal to the dentate line. As the pre-secured rubber band blocked the hepatofugal drainage, the sclerosant was forced to flow toward the cardia (▶Fig. 2 a). In this way, the role of the rubber band was similar to that of a dilated balloon in balloon-occluded retrograde transvenous obliteration and endoclip in clip-assisted gastric variceal obturation [3]. A combination of 7mL foam sclerosant (1% lauromacrogol: room air = 1:3), 1mL tissue adhesive (N-butyl-2-cyanoacrylate), and 2.5mL of normal saline was injected using a needle with a transparent catheter (23G; Boston Scientific) (▶Video 1). Hemostasis was successfully achieved (▶Fig. 2b). Enhanced computed tomography confirmed effective obliteration of varices. The patient was discharged in good condition. LOEIS is particularly suitable for GOV1/2 with large esophageal and small gastric varices. When applied properly, LOEIS is both safe and efficient. It is highly complementary to conventional endoscopic obliteration methods and should be integrated into the technical arsenal for management of gastroesophageal varices.
What problem does this paper attempt to address?